GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $221,000 | -34.0% | 6,222 | -24.4% | 0.02% | -38.5% |
| Q3 2017 | $335,000 | -21.7% | 8,232 | -17.0% | 0.04% | -25.0% |
| Q2 2017 | $428,000 | +0.2% | 9,917 | -2.0% | 0.05% | -5.5% |
| Q1 2017 | $427,000 | -10.3% | 10,119 | -18.1% | 0.06% | -17.9% |
| Q4 2016 | $476,000 | -29.6% | 12,350 | -21.1% | 0.07% | -34.3% |
| Q3 2016 | $676,000 | -15.1% | 15,662 | -14.7% | 0.10% | -16.4% |
| Q2 2016 | $796,000 | -6.1% | 18,367 | -12.1% | 0.12% | -6.2% |
| Q1 2016 | $848,000 | -36.3% | 20,907 | -36.7% | 0.13% | -38.4% |
| Q4 2015 | $1,332,000 | -0.6% | 33,029 | -5.3% | 0.21% | -8.3% |
| Q3 2015 | $1,340,000 | -9.5% | 34,864 | -1.9% | 0.23% | -3.4% |
| Q2 2015 | $1,480,000 | -22.6% | 35,529 | -14.2% | 0.24% | -27.0% |
| Q1 2015 | $1,911,000 | -26.1% | 41,408 | -31.5% | 0.33% | -29.3% |
| Q4 2014 | $2,585,000 | +44.5% | 60,493 | +55.4% | 0.46% | +36.4% |
| Q3 2014 | $1,789,000 | +621.4% | 38,924 | +739.2% | 0.34% | +604.2% |
| Q2 2014 | $248,000 | – | 4,638 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |